2011-03-01 10:35 Ulf Skough har utsetts till ny VD för A+ Science Holding AB och tillträder den 1 mars med placering i Stockholm.
Tag: cro
Pressmeddelanden
2010-08-30 22:53 Positive results from the SHIFT trial were published in the Lancet online, August 29, 2010. With more than 6500 patients in 37 countries it is the largest heart failure trial published to date. Contract research Organization A+ Science managed the coordination of sites from start up to close-out in 6 European countries.
2009-05-29 00:00 Patienter söks till en läkemedelsprövning av försöksläkemedlet Otelixizumab. Otelixizumab har i tidigare prövningar visat sig kunna bevara insulinproduktionen för patienter med tidig typ 1-diabetes i upp till 48 månader.
Visa alla 4 pressmeddelanden »
Nyheter
2011-05-23 10:32 Clinical CRO A+ Science has moved its Stockholm office to a new location. As of May 19 the new Stockholm address is at Luntmakargatan 22.
2010-02-20 11:29 The Lancet, published february 18, contained an article with further findings from the ACCOMPLISH trial.
2009-12-14 14:30 Biotech Sweden, one of the Nordic countries most read news media, elects an editorial council. The council aims to act as advisors and gather information about everything that affects the life science industry. Among the elected is A+ Science CEO, Agneta Franksson.